Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis

Early Hum Dev. 2014 Mar;90 Suppl 1:S78-83. doi: 10.1016/S0378-3782(14)70024-6.

Abstract

The purpose of this article is to study one of the most significant causes of neonatal morbidity and mortality: neonatal sepsis. This pathology is due to a bacterial or fungal infection acquired during the perinatal period. Neonatal sepsis has been categorized into two groups: early onset if it occurs within 3-6 days and late onset after 4-7 days. Due to the not-specific clinical signs, along with the inaccuracy of available biomarkers, the diagnosis is still a major challenge. In this regard, the use of a combined approach based on both nuclear magnetic resonance ((1)H-NMR) and gas-chromatography-mass spectrometry (GC-MS) techniques, coupled with a multivariate statistical analysis, may help to uncover features of the disease that are still hidden. The objective of our study was to evaluate the capability of the metabolomics approach to identify a potential metabolic profile related to the neonatal septic condition. The study population included 25 neonates (15 males and 10 females): 9 (6 males and 3 females) patients had a diagnosis of sepsis and 16 were healthy controls (9 males and 7 females). This study showed a unique metabolic profile of the patients affected by sepsis compared to non-affected ones with a statistically significant difference between the two groups (p = 0.05).

Keywords: Metabolomics; Neonatal infections; Newborn; Sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / urine
  • Case-Control Studies
  • Female
  • Humans
  • Infant, Newborn
  • Magnetic Resonance Spectroscopy
  • Male
  • Mass Spectrometry
  • Metabolome*
  • Prognosis
  • Sepsis / diagnosis*
  • Sepsis / urine

Substances

  • Biomarkers